PA Medical News about Prostate-Specific Antigen

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Benefits and harms of widespread PSA test use still unclear
JAAPA, 10/20/09

Quigley T – The prostate cancer screening controversy has become even more complex with the publication of two longawaited studies and the release of two conflicting screening guidelines...All the guidelines recommend that clinicians and patients engage in shared decision making around the topic of prostate cancer screening. Informing patients of the risks and benefits of prostate cancer screening is essential, but it is also time–consuming. The CDC has published an easy–to–read booklet, Prostate Cancer Screening: A Decision Guide, available at www.cdc.gov/cancer/prostate/basic_info/screening.htm. There are similar booklets posted for African–American men and Spanish–speaking men. These resources are intended to assist clinicians and patients in discussions leading to informed decision making regarding PSA testing.

Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging
The Journal of Urology, 11/12/09 Relevance Score: 69%

Natural History of Persistently Elevated Prostate Specific Antigen After Radical Prostatectomy: Results From the SEARCH Database
The Journal of Urology, 10/16/09 Relevance Score: 69%

Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras
The Journal of Urology, 10/21/09 Relevance Score: 68%

Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09 Relevance Score: 67%

Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r
Magnetic Resonance in Medicine, 10/09/09 Relevance Score: 66%